REGENXBIO Inc. (RGNX)
NASDAQ: RGNXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
RGNX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $501.37M
- EPS (TTM)
- -$3.78
- Dividend yield
- None
- 52-week range
- 5.46 – 16.19
- Day range
- 7.20 – 7.73
- Volume / Avg
- 1.00M / 1.53M
- Beta
- —
- Shares outstanding
- 66.01M
- Next earnings
- Nov 5, 2026
52-week range
RGNX stock today
REGENXBIO (RGNX) closed at $7.60 on Oct 7, up 1.95% (+$0.145), versus the S&P 500's 0.22% decline. Shares are 53.1% below their 52-week high of $16.19, set on Jan 22, 2026 and 39.2% above the 52-week low of $5.46, near the bottom of the past year's range. RGNX is down 47.3% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 27.7%.
REGENXBIO has posted a net loss over the last twelve months (EPS of -$3.78), so its P/E ratio is not meaningful. REGENXBIO's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About REGENXBIO
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year
- 2015
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-1.36
REGENXBIO peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ALLOAllogene Therapeutics Inc. | 1.43 | -2.05% | $494.05M | vs RGNX |
| AUTLAutolus Therapeutics plc ADR | 1.81 | +1.12% | $481.75M | vs RGNX |
| TECXTectonic Therapeutic Inc. | 22.71 | +1.34% | $443.97M | vs RGNX |
| ENTXEntera Bio Ltd. | 2.51 | -0.79% | $436.32M | vs RGNX |
| AGMBAgomAb Therapeutics NV ADR | 8.80 | -0.45% | $433.38M | vs RGNX |
| VALNValneva SE ADR | 5.87 | +0.17% | $556.61M | vs RGNX |
| EDITEditas Medicine Inc. | 2.75 | +0.73% | $422.35M | vs RGNX |
| ETRAElectra Therapeutics Inc. | 9.16 | -6.72% | $574.95M | vs RGNX |
Indexes, lists and sector
REGENXBIO stock FAQ
What is REGENXBIO's stock price today?
RGNX last traded at $7.60 as of Oct 7, 4:00 PM EDT, up 1.95% on the day. Prices are delayed at least 15 minutes.
When is REGENXBIO's next earnings date?
REGENXBIO is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-1.36.
What is the RGNX 52-week high?
The 52-week high for RGNX is $16.19 and the 52-week low is $5.46. The stock is currently 53.1% below its high.